AI Article Synopsis
- Rosai-Dorfman disease is a condition that's tough to treat, but a new method called in situ photoimmunotherapy is being tried out.
- A 39-year-old man from China had lesions on his face and was treated using a mix of cream and laser treatments over 8 weeks.
- After the treatment, his skin improved a lot, and there were no bad side effects, showing that this new therapy could work well for this disease.
Article Abstract
Rosai-Dorfman disease is difficult to cure. In situ photoimmunotherapy combines local photothermal therapy with immunoadjuvant. In the present case report, a 39-year-old Chinese man with Rosai-Dorfman disease lesions below the left nostril and left preauricular region was treated with in situ photoimmunotherapy. The patient was treated with daily application of topical imiquimod (5%) and laser irradiations every 2 weeks for 8 weeks. After three cycles of treatment, the lesions improved markedly without adverse effects. Our results showed that in situ photoimmunotherapy can be used as an effective treatment for Rosai-Dorfman disease.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.4103/ijdvl.IJDVL_356_16 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!